Investors call on covid vaccine makers to tie executive pay to global availability

€3trn investor group push comes as Moderna faces shareholder pressure over vaccine costs

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.